Evidence map›Paper›PMID 32483272›Full record

ArticleScientific reports2020

Measuring Cancer Hallmark Mediation of the TET1 Glioma Survival Effect with Linked Neural-Network Based Mediation Experiments.

Thomas Luechtefeld, Nole Lin, Channing Paller, Katherine Kuhns, John J Laterra, Joseph P Bressler

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Thomas LuechtefeldInsilica LLC, 2736 Quarry Heights Way, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-8621-1452
Nole LinInsilica LLC, 2736 Quarry Heights Way, Baltimore, MD, USA.
Channing PallerJohns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
Katherine KuhnsDepartment of Environmental Health and Engineering, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
John J LaterraJohns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
Joseph P BresslerDepartment of Environmental Health and Engineering, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA. bressler@kennedykrieger.org.ORCID http://orcid.org/0000-0002-2399-8331
Kennedy Krieger Institute · USJohns Hopkins University · USSidney Kimmel Comprehensive Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper examines the effect of TET1 expression on survival in glioma patients using open-access data from the Genomic Data Commons. A neural network-based survival model was built on expression data from a selection of genes most affected by TET1 knockdown with a median cross-validated survival concordance of 82.5%. A synthetic experiment was then conducted that linked two separately trained neural networks: a multitask model estimating cancer hallmark gene expression from TET1 expression, and a survival neural network. This experiment quantified the mediation of the TET1 survival effect through eight cancer hallmarks: apoptosis, cell cycle, cell death, cell motility, DNA repair, immune response, two phosphorylation pathways, and a randomized gene sets. Immune response, DNA repair, and apoptosis displayed greater mediation than the randomized gene set. Cell motility was inversely associated with only 12.5% mediated concordance. We propose the neural network linkage mediation experiment as an approach to collecting evidence of hazard mediation relationships with prognostic capacity useful for designing interventions.

Indexed as

Gene Regulatory NetworksBrain NeoplasmsDatabases, GeneticGene Expression ProfilingGene Expression Regulation, NeoplasticGene Knockdown TechniquesGliomaHumansMixed Function OxygenasesMutationNeural Networks, ComputerProto-Oncogene ProteinsSequence Analysis, RNASurvival AnalysisMixed Function OxygenasesProto-Oncogene ProteinsTET1 protein, human

Identifiers

PMID32483272
PMCPMC7264360
OpenAlexW3029941365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.